Stock Events

Stock Events

Janux Therapeutics (JANX) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.47

-0.31

-0.16

0

Details

Expected EPS

-0.310725

Actual EPS

-0.11

Surprise EPS

0.2

Surprise Percent

+64.6%

Description

Janux Therapeutics (JANX) has reported earnings of -0.11 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.